Cartesian Therapeutics, Inc. — Director's Dealing 2018

Dec 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2018-12-01

Reporting Person: Brunn Carsten (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-01	Stock Option (Right to Buy)	$6.03	A	1000000	Acquired	2028-11-30	Common Stock (1000000)	Direct
2018-12-01	Restricted Stock Units	$	A	175000	Acquired		Common Stock (175000)	Direct

Footnotes

F1: This option vests as to 25% on December 1, 2019. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3: This restricted stock unit vests as to 25% on December 1, 2019. The remainder of the units will vest in twelve substantially equal quarterly installments thereafter. The restricted stock units have no expiration date.